Pages that link to "Q27640463"
Jump to navigation
Jump to search
The following pages link to Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity (Q27640463):
Displaying 50 items.
- NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains (Q24324423) (← links)
- Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies (Q24561905) (← links)
- Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals (Q24635002) (← links)
- Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086 (Q24654235) (← links)
- Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop (Q27642457) (← links)
- Structure determination of an anti-HIV-1 Fab 447-52D–peptide complex from an epitaxially twinned data set (Q27650903) (← links)
- Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens (Q27658173) (← links)
- Conserved structural elements in the V3 crown of HIV-1 gp120 (Q27663325) (← links)
- The Conformation and Orientation of a 27-Residue CCR5 Peptide in a Ternary Complex with HIV-1 gp120 and a CD4-Mimic Peptide (Q27670815) (← links)
- Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected Humans (Q27679123) (← links)
- Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization (Q27684579) (← links)
- Bioinformatic analysis of HIV-1 entry and pathogenesis (Q27693321) (← links)
- Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory (Q28071559) (← links)
- Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage (Q28469177) (← links)
- Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes (Q28752503) (← links)
- Ab initio protein structure prediction with force field parameters derived from water-phase quantum chemical calculation. (Q30368444) (← links)
- Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates. (Q30370415) (← links)
- HIV immunopathogenesis and strategies for intervention. (Q30372278) (← links)
- Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies. (Q30416200) (← links)
- Multiobjective evolutionary algorithm with many tables for purely ab initio protein structure prediction (Q30430372) (← links)
- Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers (Q30580101) (← links)
- Conformational preferences of the HIV-1 principal neutralizing determinant (Q31010762) (← links)
- Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates (Q31112947) (← links)
- Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing (Q33392865) (← links)
- Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein (Q33571825) (← links)
- Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage (Q33711003) (← links)
- Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains (Q33788810) (← links)
- Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture (Q33802789) (← links)
- An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120 (Q33820645) (← links)
- Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold. (Q34128200) (← links)
- Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences (Q34267043) (← links)
- Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. (Q34434854) (← links)
- A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C. (Q34478387) (← links)
- Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1. (Q34543052) (← links)
- Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines (Q34578894) (← links)
- Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion (Q35080366) (← links)
- Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition (Q35111062) (← links)
- Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1 (Q35122067) (← links)
- β-Sheet 13C structuring shifts appear only at the H-bonded sites of hairpins (Q35136507) (← links)
- Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms (Q35161426) (← links)
- Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody. (Q35168642) (← links)
- Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design (Q35196671) (← links)
- Identifying epitopes of HIV-1 that induce protective antibodies (Q35708836) (← links)
- Progress on new vaccine strategies against chronic viral infections (Q35864857) (← links)
- Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins (Q36424523) (← links)
- Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures (Q36867198) (← links)
- The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. (Q36954472) (← links)
- Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. (Q36974754) (← links)
- N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies (Q37010852) (← links)
- Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. (Q37072702) (← links)